Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02028286 · ClinicalTrials.gov registry record · Phase 1
A 21 Day Pharmacokinetics Study in Papulopustular Rosacea
A Phase 1 study, sponsored by Maruho Co..
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
NCT02028286 is a Phase 1 study that has completed, run by Maruho Co.. The registered enrollment target is 25 participants.
The verdict
NCT02028286, a Phase 1 study, has completed, sponsored by Maruho Co..
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize the pharmacokinetics of once daily topical gel and confirm that steady state conditions are reached under maximal use conditions following 3 weeks of daily applications.
Interventions
- DRUG CLS001
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2014-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02028286
The ClinicalTrials.gov registry entry for NCT02028286 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Maruho Co., which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CLS001 is the first listed.
NCT02028286 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02028286 about?
NCT02028286 is a clinical study titled "A 21 Day Pharmacokinetics Study in Papulopustular Rosacea". The purpose of this study is to characterize the pharmacokinetics of once daily topical gel and confirm that steady state conditions are reached under maximal use conditions following 3 weeks of daily applications.
What is the current status of trial NCT02028286?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2014-01.
What interventions are being tested in trial NCT02028286?
The interventions under investigation include: CLS001 (DRUG).
Who is sponsoring clinical trial NCT02028286?
This trial is sponsored by Maruho Co., which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.